Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
Filing tables
Filing exhibits
Related press release
NVTR similar filings
Filing view
External links
EXHIBIT 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in Registration Statements Nos. 333-210150, 333-217791, and 333-223548 on Form S-8 and Registration Statement No. 333-220834 on Form S-3 of our report dated March 4, 2019, relating to the consolidated financial statements of Nuvectra Corporation and subsidiaries (which report expresses an unqualified opinion and includes an emphasis of a matter paragraph relating to the sale of NeuroNexus Technologies, Inc.) appearing in this Annual Report on Form 10-K of Nuvectra Corporation for the year ended December 31, 2018.
/s/ Deloitte & Touche LLP
Dallas, Texas
March 4, 2019